Camurus Company
Camurus AB (publ) is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Technology:
Others
Industry:
Stem Cell Exhaustion
Headquarters:
Sweden
Founded Date:
1991-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
6
Total Funding:
€10.1M
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Register and Claim Ownership